HyperArc radiotherapy for unresectable benign orbital tumours-cohort study and dosimetric comparison study
{{output}}
Objective: To report the clinical application, dosimetric features, efficacy, and toxicity profile of HyperArc (HA) for benign orbital tumours not amenable to surgical resection. ... ...
